Adam Crystal - President, Research & Development at Tango Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Research & Development
Stock Symbol
TNGX on Nasdaq
All Insider Reports
All Insider Reports

Adam Crystal - trading volume in the past year for Tango Therapeutics, Inc.

Holdings reported by Adam Crystal for Tango Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 119K $1.51M $12.62 Feb 7, 2024 Direct
Stock Option (Right to Buy) 280K Feb 1, 2024 Direct Common Stock

Transactions reported by Adam Crystal for Tango Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.